Embecta Corp. (EMBC) has a MoatMap StockRank of 94/100 based on Quality (68/100), Value (90/100), and Momentum (20/100) factor scores. The current signal is STRONG BUY. Embecta, a diabetes care device company, is trading at a significant discount (V:95) for a business in an essential healthcare segment, with good quality (Q:62).